Presentation is loading. Please wait.

Presentation is loading. Please wait.

Double-Blind Placebo-Controlled Trial of Dapsone in Antihistamine Refractory Chronic Idiopathic Urticaria  Matt Morgan, MD, Andrew Cooke, MD, Laura Rogers,

Published byZoltán Barta Modified over 5 years ago

Similar presentations

Presentation on theme: "Double-Blind Placebo-Controlled Trial of Dapsone in Antihistamine Refractory Chronic Idiopathic Urticaria  Matt Morgan, MD, Andrew Cooke, MD, Laura Rogers,"— Presentation transcript:

1 Double-Blind Placebo-Controlled Trial of Dapsone in Antihistamine Refractory Chronic Idiopathic Urticaria  Matt Morgan, MD, Andrew Cooke, MD, Laura Rogers, MD, Beverley Adams-Huet, MS, David A. Khan, MD  The Journal of Allergy and Clinical Immunology: In Practice  Volume 2, Issue 5, Pages (September 2014) DOI: /j.jaip Copyright © 2014 American Academy of Allergy, Asthma & Immunology Terms and Conditions

2 Figure 1 Study design. The Journal of Allergy and Clinical Immunology: In Practice 2014 2, DOI: ( /j.jaip ) Copyright © 2014 American Academy of Allergy, Asthma & Immunology Terms and Conditions

3 Figure 2 Study flow diagram.
The Journal of Allergy and Clinical Immunology: In Practice 2014 2, DOI: ( /j.jaip ) Copyright © 2014 American Academy of Allergy, Asthma & Immunology Terms and Conditions

4 Figure 3 Treatment-order interaction shown for WIS over 14 weeks. Dapsone (filled symbols), placebo (open symbols). The Journal of Allergy and Clinical Immunology: In Practice 2014 2, DOI: ( /j.jaip ) Copyright © 2014 American Academy of Allergy, Asthma & Immunology Terms and Conditions

5 Figure 4 Dapsone vs placebo in WHS over time. Dapsone (filled symbols), placebo (open symbols). The Journal of Allergy and Clinical Immunology: In Practice 2014 2, DOI: ( /j.jaip ) Copyright © 2014 American Academy of Allergy, Asthma & Immunology Terms and Conditions

6 Figure 5 Dapsone vs placebo in WIS over time. Dapsone (filled symbols), placebo (open symbols). The Journal of Allergy and Clinical Immunology: In Practice 2014 2, DOI: ( /j.jaip ) Copyright © 2014 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Download ppt "Double-Blind Placebo-Controlled Trial of Dapsone in Antihistamine Refractory Chronic Idiopathic Urticaria  Matt Morgan, MD, Andrew Cooke, MD, Laura Rogers,"

Similar presentations

Double-Blind Placebo-Controlled Trial of Dapsone in Antihistamine Refractory Chronic Idiopathic Urticaria  Matt Morgan, MD, Andrew Cooke, MD, Laura Rogers,

Double-Blind Placebo-Controlled Trial of Dapsone in Antihistamine Refractory Chronic Idiopathic Urticaria  Matt Morgan, MD, Andrew Cooke, MD, Laura Rogers,
D-dimer: A biomarker for antihistamine-resistant chronic urticaria

D-dimer: A biomarker for antihistamine-resistant chronic urticaria
Jonathan A. Bernstein, MD, David M. Lang, MD, David A. Khan, MD 

Jonathan A. Bernstein, MD, David M. Lang, MD, David A. Khan, MD 
Complementary and Alternative Medicine Use among Allergy Practices: Results of a Nationwide Survey of Allergists  Michael H. Land, MD, Julie Wang, MD 

Complementary and Alternative Medicine Use among Allergy Practices: Results of a Nationwide Survey of Allergists  Michael H. Land, MD, Julie Wang, MD 
The Relationship Between a Specific IgE Level and Asthma Outcomes: Results from the 2005-2006 National Health and Nutrition Examination Survey  Whitney.

The Relationship Between a Specific IgE Level and Asthma Outcomes: Results from the National Health and Nutrition Examination Survey  Whitney.
Von Ta, MD, Andrew A. White, MD 

Von Ta, MD, Andrew A. White, MD 
Advances in Diagnosing Peanut Allergy

Advances in Diagnosing Peanut Allergy
Oral Phenylephrine HCl for Nasal Congestion in Seasonal Allergic Rhinitis: A Randomized, Open-label, Placebo-controlled Study  Eli O. Meltzer, MD, Paul.

Oral Phenylephrine HCl for Nasal Congestion in Seasonal Allergic Rhinitis: A Randomized, Open-label, Placebo-controlled Study  Eli O. Meltzer, MD, Paul.
The XTEND-CIU study: Long-term use of omalizumab in chronic idiopathic urticaria  Marcus Maurer, MD, Allen Kaplan, MD, Karin Rosén, MD, PhD, Michael Holden,

The XTEND-CIU study: Long-term use of omalizumab in chronic idiopathic urticaria  Marcus Maurer, MD, Allen Kaplan, MD, Karin Rosén, MD, PhD, Michael Holden,
The Natural History of Food Allergy

The Natural History of Food Allergy
Allergy to Surgical Implants

Allergy to Surgical Implants
Chronic rhinosinusitis: Potential new use for topical sulfasalazine

Chronic rhinosinusitis: Potential new use for topical sulfasalazine
Complementary and Alternative Medicine in Allergy-Immunology: More Information is Needed  Leonard Bielory, MD  The Journal of Allergy and Clinical Immunology:

Complementary and Alternative Medicine in Allergy-Immunology: More Information is Needed  Leonard Bielory, MD  The Journal of Allergy and Clinical Immunology:
Eosinophilia-Associated Coronary Artery Vasospasm in Patients with Aspirin- Exacerbated Respiratory Disease  Neelam H. Shah, MD, Thomas R. Schneider, BA,

Eosinophilia-Associated Coronary Artery Vasospasm in Patients with Aspirin- Exacerbated Respiratory Disease  Neelam H. Shah, MD, Thomas R. Schneider, BA,
Urticaria Multiforme in an 18-Year-Old Girl

Urticaria Multiforme in an 18-Year-Old Girl
Treatment of chronic rhinosinusitis with intranasal amphotericin B: A randomized, placebo-controlled, double-blind pilot trial  Jens U. Ponikau, MD, David.

Treatment of chronic rhinosinusitis with intranasal amphotericin B: A randomized, placebo-controlled, double-blind pilot trial  Jens U. Ponikau, MD, David.
Wells Syndrome with Bullous Lesions

Wells Syndrome with Bullous Lesions
Dennis K. Ledford, MD, Sally Wenzel, MD 

Dennis K. Ledford, MD, Sally Wenzel, MD 
Shyam Joshi, MD, David A. Khan, MD 

Shyam Joshi, MD, David A. Khan, MD 
Jennie Gane, MBChB (Hons), MSc, Roger Buckley, BM BCh, MA, FRCS 

Jennie Gane, MBChB (Hons), MSc, Roger Buckley, BM BCh, MA, FRCS 

Similar presentations

Ads by Google